))
Establishing Direct-to and from-Patient Clinical Trials (Part 1)
Manage episode 402253684 series 3554424
Content provided by Quick Group of Companies. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Quick Group of Companies or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Critically ill patients increasingly can participate in life saving and life changing cell & gene therapy clinical trials without having to leave their homes with the Direct- to -Patient and Direct- from -Patient model. So how do you set up these supply chains? How do you mitigate risk? And how do you ensure they’re resilient? Mike Sweeney, QuickSTAT’s Global Head of Strategy for CGT and Direct to Patient products, explains.
5 episodes
Share
